What is DTC?
Established in 1986, Diagnostic Technology Consultants, Inc. serves as a critical infrastructure partner for the healthcare industry, specializing in medical physics and radiation safety. The firm provides a comprehensive suite of services, including radiology support, nuclear medicine, and rigorous accreditation compliance. By offering specialized expertise in shielding design, dose calculations, and clinical education, DTC ensures that healthcare providers maintain the highest standards of safety and quality. Their market position is defined by decades of technical precision and a deep understanding of the evolving compliance demands within radiology and oncology departments nationwide.
How much funding has DTC raised?
DTC has raised a total of $150K across 1 funding round:
Debt
$150K
Debt (2020): $150K with participation from PPP
Key Investors in DTC
PPP
Public-Private Partnership
What's next for DTC?
With this late-stage capital, DTC is well-positioned to scale its service offerings and potentially integrate advanced digital compliance tools to streamline its radiation safety workflows. The strategic focus will likely shift toward expanding its footprint in high-growth clinical environments that require sophisticated shielding and regulatory oversight. By leveraging this investment, the company aims to solidify its role as a primary consultant for large-scale healthcare networks, ensuring that its legacy of clinical precision remains a cornerstone of its future growth trajectory in the medical physics domain.
See full DTC company page
